SCHEMBL5076464

SCHEMBL5076464

CC(C)CCCS(=O)(=O)I

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
BLM P54132 1/20 0.32
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5079866 0.92 LMNA (0.42) LMNABLMMEN1ALDH1A1HTT
SCHEMBL5075273 0.90 LMNA (0.40) LMNABLM
SCHEMBL5075757 0.83
SCHEMBL17369606 0.78 LMNA (0.41) LMNABLMMEN1ALDH1A1HTT
SCHEMBL329051 0.76 LMNA (0.39) LMNABLMMEN1ALDH1A1HTT
SCHEMBL5635440 0.76 LMNA (0.39) LMNABLMMEN1ALDH1A1HTT
SCHEMBL224000 0.74 LMNA (0.38) LMNABLMMEN1ALDH1A1HTT
SCHEMBL3067524 0.74 LMNA (0.38) LMNABLMMEN1ALDH1A1HTT
SCHEMBL223999 0.74 LMNA (0.38) LMNABLMMEN1ALDH1A1HTT
SCHEMBL2304954 0.74 LMNA (0.38) LMNABLMMEN1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2757102-B1 Intermediate for producing a cyclic sulfonic acid ester WAKO PURE CHEM IND LTD (JP) 2016-03-23 EP disclosed
US-8969591-B2 Method for producing cyclic sulfonic acid ester and intermediate thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2015-03-03 US disclosed
EP-2463281-B1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEM IND LTD (JP) 2014-10-22 EP disclosed
EP-2757102-A1 1,3-propanesultone derivative useful in the preparation of a 1,3-propenesultone derivative Wako Pure Chemical Industries, Ltd. (JP) 2014-07-23 EP disclosed
US-20140142324-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-22 US disclosed
US-8673963-B2 Method for producing cyclic sulfonic acid ester and intermediate thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-18 US disclosed
EP-2463281-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130089-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed
EP-1413572-B1 PROCESS FOR PRODUCING ACID ANHYDRIDE TOKUYAMA CORP (JP) 2008-10-08 EP disclosed
US-7220881-B2 Process for production of acid anhydride TOKUYAMA CORPORATION (JP) 2007-05-22 US disclosed
CN-1220676-C Method for producing acid anhydride TOKUYAMA CORP (JP) 2005-09-28 CN disclosed
US-20040242929-A1 Process for production of acid anhydride TOKUYAMA CORPORATION (JP) 2004-12-02 US disclosed
CN-1537097-A Method for producing acid anhydride ��ʽ�����ɽ 2004-10-13 CN disclosed
EP-1413572-A1 PROCESS FOR PRODUCING ACID ANHYDRIDE Tokuyama Corporation (JP) 2004-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142324-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF STS, TST, SULT1A1 LMNA 3063/4885BLM 4122/4885MEN1 3976/4885
US-20120130089-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF STS, TST, SULT1A1 LMNA 3063/4885BLM 4122/4885MEN1 3976/4885
US-20040242929-A1 Process for production of acid anhydride CA4, CA9, CA6 LMNA 3774/4885BLM 4374/4885MEN1 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.